300888.SZ

Winner Medical Co., Ltd. [300888.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

300888.SZ Stock Summary

Earnings have grown 41.23% per last year.

Earnings are expected to fall -100% next year

300888.SZ has less than 1 year of cash runway

Top 10 Correlated ETFs

300888.SZ

Top 10 Correlated Stocks

300888.SZ

In the News

300888.SZ Financial details

Company Rating

Strong Buy

Market Cap

19.27B

Income

2.55B

Revenue

9.72B

Book val./share

22.39

Cash/share

12.96

Dividend

1.9

Dividend %

5.11%

Employees

14.94K

Optionable

Shortable

Yes

Earnings

25 Apr 2024

P/E

8.61

Forward P/E

PEG

0.79

P/S

2.24

P/B

1.67

P/C

2.58

P/FCF

76.55

Quick Ratio

2.22

Current Ratio

2.62

Debt / Equity

0.16

LT Debt / Equity

0.03

EPS (TTM)

4.35

EPS next Y

EPS next Q

EPS this Y

35.1%

EPS next Y

EPS next 5Y

EPS last 5Y

28.25%

Revenue last 5Y

24.21%

Revenue Q/Q

-8.94%

EPS Q/Q

382.69%

SMA20

-8.11%

SMA50

-2.86%

SMA100

-15%

Inst Own

Inst Trans

ROA

13%

ROE

21%

ROC

0.2%

Gross Margin

49%

Oper. Margin

31%

Profit Margin

26%

Payout

12%

Shs Outstand

Shs Float

Target Price

52W Range

29.25-46.635715

52W High

-27.41%

52W Low

+15.14%

RSI

Rel Volume

0.56

Avg Volume

2.87M

Volume

1.6M

Perf Week

-1.15%

Perf Month

-6.05%

Perf Quarter

-13.61%

Perf Half Y

-19.23%

Beta

0.437

Volatility

0.33%, 1.19%

Prev Close

-1.94%

Price

33.39

Change

-0.92%

300888.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	7.36	7.66	20.99	13.48	19.32
Net income per share	0.81	0.91	6.38	2.08	2.81
Operating cash flow per share	0.9	1	7.98	1.46	5.08
Free cash flow per share	-0.33	0.26	7.02	0.22	3.04
Cash per share	0.51	0.53	13.89	12.42	15.16
Book value per share	5.09	5.29	17.51	17.9	19.92
Tangible book value per share	4.85	5.08	17.18	17.48	17.2
Share holders equity per share	5.09	5.29	17.51	17.9	19.92
Interest debt per share	0.64	0.48	0.87	1.05	4.91
Market cap	47.02B	53.84B	70.8B	35.11B	30.01B
Enterprise value	46.92B	53.62B	66.79B	31.44B	28.32B
P/E ratio	110.73	98.55	18.58	28.33	18.18
Price to sales ratio	12.25	11.77	5.65	4.37	2.64
POCF ratio	100.51	89.76	14.85	40.28	10.06
PFCF ratio	-276.15	352.17	16.88	273.43	16.82
P/B Ratio	17.7	17.03	6.77	3.29	2.56
PTB ratio	17.7	17.03	6.77	3.29	2.56
EV to sales	12.22	11.72	5.33	3.91	2.5
Enterprise value over EBITDA	73.33	70.17	13.52	16.03	9.85
EV to operating cash flow	100.29	89.4	14.01	36.07	9.49
EV to free cash flow	-275.57	350.74	15.92	244.81	15.87
Earnings yield	0.01	0.01	0.05	0.04	0.05
Free cash flow yield	0	0	0.06	0	0.06
Debt to equity	0.11	0.08	0.05	0.06	0.24
Debt to assets	0.08	0.06	0.04	0.05	0.16
Net debt to EBITDA	-0.16	-0.28	-0.81	-1.87	-0.59
Current ratio	1.54	2.25	4.53	4.99	2.21
Interest coverage	16.22	25.77	1.25K	49.21	39.5
Income quality	1.1	1.1	1.25	0.7	1.78
Dividend Yield	0	0	0	0.02	0.01
Payout ratio	0.14	0.1	0.03	0.62	0.24
Sales general and administrative to revenue	-0.03	-0.03	0.01	0.01	0.01
Research and developement to revenue	0.03	0.03	0.03	0.04	0.04
Intangibles to total assets	0.03	0.03	0.02	0.02	0.11
Capex to operating cash flow	-1.36	-0.75	-0.12	-0.85	-0.4
Capex to revenue	-0.17	-0.1	-0.05	-0.09	-0.11
Capex to depreciation	-6.76	-4.32	-3.61	-1.97	-2.49
Stock based compensation to revenue	0	0	0	0	0
Graham number	9.66	10.44	50.14	28.94	35.48
ROIC	0.14	0.16	0.34	0.11	0.12
Return on tangible assets	0.11	0.12	0.3	0.1	0.1
Graham Net	-0.28	0.47	12.48	10.97	8.15
Working capital	683.15M	1.49B	8.56B	8.27B	6.64B
Tangible asset value	2.53B	3.03B	10.26B	10.42B	10.1B
Net current asset value	641.53M	1.31B	8.46B	7.77B	6.07B
Invested capital	0.11	0.08	0.05	0.06	0.24
Average receivables	549.13M	865.54M	1.28B	1.33B	1.38B
Average payables	695.57M	692.89M	745.9M	763.36M	957.53M
Average inventory	802.59M	917.74M	1.1B	1.41B	1.58B
Days sales outstanding	58.34	89.16	42.07	55.64	49.59
Days payables outstanding	121.56	121.42	54.42	69.84	69.93
Days of inventory on hand	157.67	163.76	87.57	144.74	95.27
Receivables turnover	6.26	4.09	8.68	6.56	7.36
Payables turnover	3	3.01	6.71	5.23	5.22
Inventory turnover	2.31	2.23	4.17	2.52	3.83
ROE	0.16	0.17	0.36	0.12	0.14
Capex per share	-1.22	-0.75	-0.96	-1.25	-2.04

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	5.84	6.31	4	3.27	2.98
Net income per share	0.84	0.68	0.64	0.52	2.51
Operating cash flow per share	0.84	0.68	0.64	0.65	0.11
Free cash flow per share	0.01	0.12	0.16	0.41	-0.2
Cash per share	17.01	15.16	14.72	13.62	12.96
Book value per share	26.75	19.92	20.6	19.84	22.39
Tangible book value per share	23.46	17.2	17.93	17.17	19.74
Share holders equity per share	26.75	19.92	20.6	19.84	22.39
Interest debt per share	5.78	4.89	5.33	4.2	3.55
Market cap	20.83B	30.01B	27.79B	24.37B	24.02B
Enterprise value	19.46B	28.32B	26.52B	22.47B	22.22B
P/E ratio	14.57	18.74	18.43	20	4.1
Price to sales ratio	8.38	8.09	11.81	12.73	13.77
POCF ratio	58.27	74.97	73.72	63.9	374.13
PFCF ratio	6.23K	436.92	300.84	100.65	-201.61
P/B Ratio	1.83	2.56	2.3	2.1	1.83
PTB ratio	1.83	2.56	2.3	2.1	1.83
EV to sales	7.83	7.64	11.27	11.74	12.74
Enterprise value over EBITDA	47.39	33.78	51.46	52.09	154.99
EV to operating cash flow	54.44	70.75	70.35	58.91	346.09
EV to free cash flow	5.82K	412.33	287.09	92.78	-186.5
Earnings yield	0.02	0.01	0.01	0.01	0.06
Free cash flow yield	0	0	0	0.01	0
Debt to equity	0.22	0.24	0.26	0.21	0.16
Debt to assets	0.15	0.16	0.17	0.14	0.11
Net debt to EBITDA	-3.34	-2.02	-2.46	-4.42	-12.56
Current ratio	2.63	2.21	2.57	2.5	2.62
Interest coverage	-81.02	13.58	29.08	21.16	112.12
Income quality	1	1	1	1.25	0.04
Dividend Yield	0	0	0	0.01	0
Payout ratio	0.04	0.02	0.01	0.91	0
Sales general and administrative to revenue	0.16	-0.1	0.06	-0.05	0.22
Research and developement to revenue	0.05	0.03	0.05	0.04	0.04
Intangibles to total assets	0.11	0.11	0.11	0.12	0.11
Capex to operating cash flow	-0.99	-0.83	-0.75	-0.37	-2.86
Capex to revenue	-0.14	-0.09	-0.12	-0.07	-0.11
Capex to depreciation	-2.28	-2.14	-2.05	-1	0.73
Stock based compensation to revenue	-0.02	0	0	0	0
Graham number	22.5	17.47	17.24	15.25	35.54
ROIC	0.03	0.03	0.02	0.02	0.1
Return on tangible assets	0.02	0.02	0.02	0.02	0.09
Graham Net	10.99	8.15	8.55	7.56	6.96
Working capital	6.69B	6.64B	7.14B	6.46B	6.66B
Tangible asset value	9.97B	10.1B	10.53B	10.04B	11.55B
Net current asset value	6.14B	6.07B	6.27B	5.61B	5.36B
Invested capital	0.22	0.24	0.26	0.21	0.16
Average receivables	1.66B	1.54B	1.49B	1.33B	1.38B
Average payables	975.1M	975.76M	1.01B	882.23M	929.6M
Average inventory	1.85B	1.72B	1.51B	1.44B	1.44B
Days sales outstanding	55.82	37.42	55.03	57.25	79.69
Days payables outstanding	54.08	51.78	68.1	87.42	94.28
Days of inventory on hand	126.19	70.54	113.75	138.58	142.8
Receivables turnover	1.61	2.4	1.64	1.57	1.13
Payables turnover	1.66	1.74	1.32	1.03	0.95
Inventory turnover	0.71	1.28	0.79	0.65	0.63
ROE	0.03	0.03	0.03	0.03	0.11
Capex per share	-0.83	-0.56	-0.48	-0.24	-0.31

300888.SZ Dividend History

300888.SZ Frequently Asked Questions

What is Winner Medical Co., Ltd. stock symbol ?

Winner Medical Co., Ltd. is a CN stock and trading under the symbol 300888.SZ

What is Winner Medical Co., Ltd. stock quote today ?

Winner Medical Co., Ltd. stock price is $33.39 today.

Is Winner Medical Co., Ltd. stock public?

Yes, Winner Medical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 2.87M
Market Capitalization 19.27B
Employee 14.94K
CEO Mr. Jianquan Li
Headquarters Shenzhen,CN
IPO Date 2020-09-17
Website https://www.winnermedical.com

Winner Medical Co., Ltd. engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China. It operates through, Medical Consumables and Healthy Consumer Goods segments. The company offers wound care products, including gauze sheets, non-woven sheets, gauze bandage, dressing change kits, silicone dressings, alginate dressings, etc.; infection prevention products, such as surgical packs, surgical gowns, masks, protective clothing, isolation gowns, gloves, footwear, hats, etc.; and disinfection and cleaning products comprising cotton swabs, cotton pads, cotton balls, alcohol cotton pads, disinfectant, etc. It also offers non-woven fabric; non-woven consumer goods, such as cotton tissues, wet wipes, sanitary pads, cotton swabs, makeup cotton pads, disposable underwear, etc.; and textile consumer goods, including baby supplies and clothing, adult clothing, and other textile consumer goods. The company provides its products under the winner, Purcotton, and PureH2B brands through pharmacy chain store, hospital, e-commerce, and supermarket distribution channels. The company also sells its products to approximately 110 countries worldwide. Winner Medical Co., Ltd. was founded in 1991 and is based in Shenzhen, China. Winner Medical Co., Ltd. is a subsidiary of Winner Group Limited.